Genetic engineering: moral aspects and control of practice
- PMID: 9226508
- PMCID: PMC3454796
- DOI: 10.1007/BF02765833
Genetic engineering: moral aspects and control of practice
Abstract
Present-day scientific advances have made it possible to use somatic cell gene therapy for the treatment of serious human genetic disease. Gene therapy is enormously important for curing some diseases, otherwise untreatable. The technical ability to perform germline gene alteration is also under way. Society must determine its attitude toward germline alteration and toward intervention for the purpose of genetic enhancement. Eugenic genetics is purely theoretical at present and is likely to remain so for a long time. Articles in the press, sometimes influenced by specific pressure groups, generate public fear that is in most cases unfounded, due to the lack of feasibility of performing the claims voiced in them. Still, society must be concerned about the possibility that gene therapy will be misused in the future. Gene therapy should only be used in ways that maintain human dignity. The best insurance against misuse is a public well informed and not unnecessarily frightened. With proper safeguards imposed by society, gene therapy can be ethically used.
Similar articles
-
Scientific and ethical considerations in human gene therapy.Baillieres Clin Obstet Gynaecol. 1991 Sep;5(3):697-713. doi: 10.1016/s0950-3552(05)80265-2. Baillieres Clin Obstet Gynaecol. 1991. PMID: 1954734 Review. No abstract available.
-
Gene therapy and genetic alteration.Hum Gene Ther. 1994 May;5(5):603-14. doi: 10.1089/hum.1994.5.5-603. Hum Gene Ther. 1994. PMID: 8054376 Review. No abstract available.
-
The new gene technology and the difference between getting rid of illness and altering people.Eur J Genet Soc. 1995;1(1):12-20. doi: 10.1179/hrge.1.1.276042718403jh80. Eur J Genet Soc. 1995. PMID: 11653050 No abstract available.
-
Reprogenetics policy: three kinds of models.Community Genet. 1998;1(2):61-70. doi: 10.1159/000016139. Community Genet. 1998. PMID: 11657630 No abstract available.
-
Commentary: maintaining the somatic/germ-line distinction: some ethical drawbacks.J Med Philos. 1991 Dec;16(6):641-7. doi: 10.1093/jmp/16.6.641. J Med Philos. 1991. PMID: 1787392
References
-
- Wolff JA, Lederberg J. An early history of gene transfer and therapy. Hum Gene Ther. 1994;5:469–480. - PubMed
-
- Lwoff A. Nobel Lectures in Physiology or Medicine, 1963–1970. Boston: Elsevier; 1972. Interaction among virus, cell and organism: Nobel lecture. December 11, 1965; pp. 174–185.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical